AI in medical writing market is anticipated to grow at a CAGR of 16.1% during the forecast period (2023-2030). AI in medical writing is a highly specialized field that encompasses the art and science of content writing and clinical research. It involves the production of well-structured scientific resources including clinical research papers, web content for the healthcare industry, periodicals, and journals, among others. Employing the capabilities of a software process called as natural language generation (NLG), AI has the ability to produce complex documents in a significantly reduced timeframe compared to conventional methods (from weeks down to mere days). This accelerated production timeline subsequently increases the submissions and approval processes, benefiting both pharmaceutical and communication companies. This efficiency gain becomes a pivotal driver supporting the global market's growth. 

Segmental Outlook 

The global AI in medical writing market is segmented on the type, and end user. Based on the type, the market is sub- segmented into clinical writing, type writing, scientific writing, and others. Based on the end user, the market is sub-segmented into medical devices, pharmaceutical, biotechnology and others. Among the type, the clinical writing sub-segment is anticipated to hold a considerable share of the market. This growth can be attributed to the essential role that clinical writing plays in the daily practices of medical professionals. A proficient clinical writer must possess a comprehensive understanding of both the clinical landscape and the language intricacies involved. The escalating number of clinical trials further contributes to this scenario, creating a surge in the requirement for AI-powered solutions in medical writing.

The Pharmaceutical Sub-Segment is Anticipated to Hold a Considerable Share of the Global AI in Medical Writing Market

Among the end user, the pharmaceutical sub-segment is expected to hold a considerable share of the global AI in medical writing market. The segmental growth is attributed to the advancements and precision achieved by AI in medical treatments. This progress has pushed significant players in the pharmaceutical industry to focus on investing in effective AI writing solutions wihitn their organizations. Many are also forging partnerships with AI-based firms, a strategic move that further propels the expansion of the market. For instance, in June 2022, Yesop, a company specializing in AI and Natural Language Processing (NLP), partnered with Sanofi to enhance the automation of safety reports. Sanofi is now using the Yseop platform for pharma and vaccine used cases in a push to expedite clinical trial dossier submission workflows.

Regional Outlook

The global AI in medical writing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising expenditure in healthcare coupled with the growing demand for efficient healthcare solutions. Additionally, the rapid technological advancements in countries such as China, Japan, South Korea, and India have been at the forefront of technological advancements in AI.

Global Artificial Intelligence (AI) in Medical Writing Market Growth by Region 2023-2030

The North America Region is Expected to Grow at a Significant CAGR in the Global AI in medical writing Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to Regulatory standards have changed quickly, and spending on research and development has been rising constantly, also due to rising healthcare expenditure and demand for efficient healthcare solutions. With the advancement of artificial intelligence technology in recent years, including successes like natural language processing (NLP) and machine learning (ML), the pharmaceuticals industry has begun to realize greater benefits from data technology. AI technologies are already playing a substantive role in clinical trials, speeding the process of research, and enhancing the quality of results. NLP is of great benefit to help extract real world data (RWD) from the treasure troves of data that are in healthcare ecosystems, such as hospital information systems, insurance claim databases, etc.

Hence, there is considerable shift of the country towards the adoption of the AI writing market solutions. 

Market Players Outlook

The major companies serving the AI in medical writing market include Parexel International Corporation., Trilogy Writing & Consulting GmbH, Freyr, Cactus Communications, and GENINVO, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Parexel International Corp. is applying AI technologies in clinical trials from the perspective of pharmacovigilance processes.

The Report Covers

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global AI in medical writing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.